以glp -1为基础的药物治疗糖尿病不会增加IBD的风险

{"title":"以glp -1为基础的药物治疗糖尿病不会增加IBD的风险","authors":"Heidi Søgaard Christensen, S. Kammerer","doi":"10.55788/46c0fa13","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":438701,"journal":{"name":"Medicom Conference Report ECCO 2023","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetes therapy with GLP-1-based drugs does not elevate the risk of IBD\",\"authors\":\"Heidi Søgaard Christensen, S. Kammerer\",\"doi\":\"10.55788/46c0fa13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":438701,\"journal\":{\"name\":\"Medicom Conference Report ECCO 2023\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report ECCO 2023\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/46c0fa13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report ECCO 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/46c0fa13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}